Pharmacokinetics of intravenous moxifloxacin in the cerebrospinal fluid of a patient with central nervous system shunt infection.
We report the first case describing the pharmacokinetics of moxifloxacin in the cerebrospinal fluid after multiple-dose intravenous administration in a patient with central nervous system shunt infection. The ratio of the area under the concentration-time curve over 24h (AUC) in cerebrospinal fluid to the AUC in serum was 0.7 in this patient.